Status:
RECRUITING
Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease
Lead Sponsor:
Tianjin Medical University
Collaborating Sponsors:
Tianjin Medical University General Hospital
Conditions:
Sympathetic Nervous System Diseases
Sympathetic Nervous Structure Injury
Eligibility:
All Genders
18-80 years
Brief Summary
To evaluate the potential usefulness of 11C/18F-HED positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patien...
Detailed Description
Subjects with various sympathetic nerves-related disease patients underwent 11C/18F-HED PET/CT either for an initial assessment or for recurrence detection. Lesions uptake was quantified by the maximu...
Eligibility Criteria
Inclusion
- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled HED PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Exclusion
- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06951984
Start Date
March 1 2013
End Date
March 1 2028
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China, 300052